Association between catechol-O-methyltransferase functional polymorphism and male suicide completers

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Suicide is potentially linked to catecholaminergic system dysfunction and genetic factors.
• The Catechol-O-methyltransferase (COMT) gene plays a crucial role in catecholamine metabolism.
• The COMT 158Val/Met polymorphism influences enzyme activity, with Val/Val genotypes exhibiting higher activity.

Purpose of the Study:

• To investigate the association between the COMT 158Val/Met polymorphism and suicide.
• To determine if this genetic polymorphism differs between suicide completers and control groups.

Main Methods:

• Genotyping analysis of the COMT 158Val/Met polymorphism.
• Comparison of genotype distributions in 163 suicide completers (112 males, 51 females) and control groups.
• Statistical analysis including odds ratios and confidence intervals.

Main Results:

• A significant difference in genotype distribution was observed between male suicide completers and male controls (p=0.036).
• The high-activity Val/Val genotype was significantly less frequent in male suicide completers compared to male controls (OR: 0.52; 95% CL: 0.31-0.89; p=0.016).
• No significant association was found in the female study population.

Conclusions:

• The COMT 158Val/Met polymorphism is differentially distributed in males based on suicide completion.
• The Val/Val genotype of the COMT gene appears to be a protective factor against suicide in males.
• Further research is warranted to explore sex-specific genetic contributions to suicide risk.